Text Size
2 studies found for:    SLC2A2

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed An Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment
Conditions: Diabetes Mellitus, Type 2;   Renal Insufficiency
Interventions: Drug: Canagliflozin 100 mg;   Drug: Canagliflozin 300 mg;   Drug: Placebo
2 Completed A First-in-Human Study of JNJ-28431754 in Healthy Male Volunteers
Condition: Healthy
Interventions: Drug: JNJ-28431754/ Placebo;   Drug: JNJ-28431754
To Top

† Indicates status has not been verified in more than two years